[go: up one dir, main page]

US20200086321A1 - Method and Device for Encapsulating Cell in Liquid Droplet for Single-Cell Analysis - Google Patents

Method and Device for Encapsulating Cell in Liquid Droplet for Single-Cell Analysis Download PDF

Info

Publication number
US20200086321A1
US20200086321A1 US16/686,613 US201916686613A US2020086321A1 US 20200086321 A1 US20200086321 A1 US 20200086321A1 US 201916686613 A US201916686613 A US 201916686613A US 2020086321 A1 US2020086321 A1 US 2020086321A1
Authority
US
United States
Prior art keywords
cell
channel
bead
cells
droplet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/686,613
Other languages
English (en)
Inventor
Woong-Yang Park
Hui-Sung MOON
Shin-Hyun Kim
Kwanghwi Je
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samsung Life Public Welfare Foundation
Original Assignee
Samsung Life Public Welfare Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Life Public Welfare Foundation filed Critical Samsung Life Public Welfare Foundation
Assigned to SAMSUNG LIFE PUBLIC WELFARE FOUNDATION reassignment SAMSUNG LIFE PUBLIC WELFARE FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JE, Kwanghwi, KIM, SHIN-HYUN, MOON, HUI-SUNG, PARK, WOONG-YANG
Publication of US20200086321A1 publication Critical patent/US20200086321A1/en
Priority to US17/962,752 priority Critical patent/US12226773B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502776—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for focusing or laminating flows
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
    • B01L3/502792—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics for moving individual droplets on a plate, e.g. by locally altering surface tension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0636—Focussing flows, e.g. to laminate flows
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0652—Sorting or classification of particles or molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0668—Trapping microscopic beads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0681—Filter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/088—Channel loops
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0883—Serpentine channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/08—Regulating or influencing the flow resistance
    • B01L2400/084—Passive control of flow resistance
    • B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/629—Detection means characterised by use of a special device being a microfluidic device

Definitions

  • the present disclosure relates to a method and a device for encapsulating a cell in droplet for single-cell analysis, or a method and a device for forming droplet for single-cell analysis.
  • Cell analysis using microfluids may be utilized particularly for single-cell genome analysis. Genetic heterogeneity, which occurs at a single-cell level in cancer, is an important clue for precise diagnosis and prognosis prediction of cancer, and in this regard, the importance of single-cell analysis is significantly increasing.
  • the single-cell analysis may be applied to many studies associated with not only cancer, but also identification of cells made of IPS cells or stem cells and subtype analysis of cell bodies.
  • a step of independently reacting individual cells is carried out by isolation and compartmentalization of cells into a single-cell unit before experiment.
  • Techniques of isolation and compartmentalization into single cells largely include a method of putting one cell into one well by using a valve and a micro-well and a method of putting one cell into one water droplet in oil by using emulsion.
  • the latter method using emulsion has advantages of enabling encapsulation of a cell and a particle in droplet, resulting in fast, accurate, and efficient genome analysis of single cells. In particular, as shown in FIG.
  • single-cell RNA sequencing analyzes a base sequence through processes of dissolving single cells to extract RNA therefrom, producing cDNA by reverse transcription, and preparing a standardized sequencing after amplification of the cDNA.
  • processes associated with each one of the single cells would cause a lot of time, labor, and cost
  • a method of indexing single cell-originated RNA with a single barcode and pooling the indexed RNA at a step of reverse transcription or amplification to proceed the next step is recently used.
  • the present disclosure provides a method and a device for encapsulating a cell in droplet for single-cell analysis, so as to improve the two conflicting parameters described above, in terms of single-cell analysis for droplet sequencing.
  • the present disclosure provides a method of forming droplet for single-cell analysis, the method including: providing cells; providing one or more distinctly barcoded RNA capture beads; and encapsulating in one droplet a single cell of the cells and a single bead of the one or more distinctly barcoded RNA capture beads, wherein the providing of the cells or the providing of the one or more distinctly barcoded RNA capture beads is provided through inertial ordering before the single cell or the single bead are encapsulated in the one droplet.
  • the inertial ordering may occur through a spiral channel of a microfluidic device to which the cells or the one or more distinctly barcoded RNA capture beads are provided.
  • the method may further include providing one or more oils (carrier oils).
  • the inertial ordering may be to improve a ratio at which the single cell and the single bead are encapsulated in the one droplet.
  • the providing of the cells or the providing of the cells or the one or more distinctly barcoded RNA capture beads may be provided at a flow rate of at least 1.0 ml/h or higher.
  • the providing of the one or more carrier oils may be provided at a flow rate of at least 2 ml/h or higher.
  • the one or more distinctly barcoded RNA capture beads may be provided in a cell lysate or with a cell lysate.
  • the one or more distinctly barcoded RNA capture beads may include multiple nucleotides or oligonucleotides, each molecularly barcoded on a surface of the one or more distinctly barcoded RNA capture beads.
  • the multiple nucleotides or oligonucleotides may include a nucleotide sequence for capturing mRNA in the cells.
  • a sequence of the multiple nucleotides or oligonucleotides may include an oligo-dT sequence or a primer sequence.
  • a microfluidic device for forming droplet for single-cell analysis including: a cell inlet including a first channel; an RNA capture bead inlet including a second channel; an oil phase inlet including a third channel; an intersection point at which the first channel, the second channel, and the third channel are combined; and an outlet connected to the intersection point and discharging droplet containing the cells and RNA containing a cell and an RNA capture bead, wherein the first channel or the second channel is configured for a cell or an RNA capture bead in a fluid to occur inertial ordering.
  • first channel and/or the second channel may be spiral shaped.
  • the cell inlet, the RNA capture bead inlet, or the oil phase inter may further include a filter.
  • effects of using inertial ordering may not only increase a ratio at which one cell is encapsulated in one droplet, but also improve a yield of producing droplet.
  • FIG. 1 is a diagram illustrating the principle of droplet sequencing.
  • FIG. 2 is a diagram showing a droplet-forming microfluidic device in the related art.
  • FIG. 3 is a diagram showing a droplet-forming microfluidic device according to an embodiment in which inertial ordering occurs at a bead inlet.
  • FIG. 4 is a diagram showing a droplet-forming microfluidic device according to an embodiment in which inertial ordering occurs at both a bead inlet and a cell inlet.
  • FIG. 5A is a photograph showing the alignment of particles using a microfluidic device in the related art.
  • FIG. 5B is a photograph showing the alignment of particles using a microfluidic device according to an embodiment.
  • FIG. 6 is a graph showing a cell throughput per time and a cell yield per time according to the bead concentration in a microfluidic device according to an embodiment, as compared to an existing system, wherein p indicates an existing system, and o indicates a system according to an embodiment.
  • FIG. 7 is a graph showing a ratio of the number of cells to be encapsulated in droplet according to the bead concentration in a microfluidic device according to an embodiment, as compared to an existing system, wherein p indicates an existing system, o indicates a system according to an embodiment, 1 indicates a case where the number of cells to be encapsulated in droplet is one, 2 indicates a case where the number of cells to be encapsulated in droplet is two, and m indicates a case where the number of cells to be encapsulated in droplet is three or more.
  • FIG. 8A is a diagram showing a lateral position in a spiral channel according to an embodiment.
  • FIG. 8B is a graph showing bead distribution along the length of the lateral position in the spiral channel according to an embodiment.
  • FIG. 9A is an optical microscope image showing droplets collected by using a microfluidic device according to an embodiment, wherein a scale bar herein is 200 um.
  • FIG. 9B is a graph showing fraction (%) of droplets containing a single bead and droplets containing multiple beads collected according to the bead concentration by using a microfluidic device according to an embodiment.
  • FIG. 10A is a graph showing a throughput and a cell yield according to the bead concentration in a microfluidic device according to an embodiment.
  • FIG. 10B is a graph showing fraction of droplets containing a single cell and a single bead according to the bead concentration in a microfluidic device according to an embodiment.
  • FIG. 10C is a graph showing fraction of droplets containing a single cell and a single bead according to the bead concentration in a microfluidic device according to an embodiment.
  • FIG. 11A is a graph showing a density plot of UMIs per cell of combined human and mouse cells according to the existing microfluidic device (Unordered) and the microfluidic device according to an embodiment (Ordered).
  • FIG. 11B is a graph showing a density plot of UMIs per cell of only human cells according to the existing microfluidic device (Unordered) and the microfluidic device according to an embodiment (Ordered).
  • FIG. 11C is a graph showing a density plot of UMIs per cell of only mouse cells according to an existing microfluidic device (Unordered) and a microfluidic device according to an embodiment (Ordered).
  • An aspect provides a method of forming droplet for single-cell analysis, the method including: providing cells; providing one or more distinctly barcoded RNA capture beads; and encapsulating in one droplet a single cell of the provided cells and a single bead of the one or more distinctly barcoded RNA capture beads, wherein the providing of the cells or the providing of the one or more distinctly barcoded RNA capture beads is provided through inertial ordering before the single cell and the single bead are encapsulated in the one droplet.
  • droplet refers to a small volume of liquid, typically in a spherical shape, surrounded by an immiscible fluid such as a continuous phase of emulsion.
  • micro-droplet may have a value of about 1 microliter or less, for example, a value between about 1 microliter and about 1 nanoliter, or a value between about 1 microliter and about 1 picoliter.
  • micro-droplet may refer to a dispersed phase having a diameter of less than about 200 micrometers.
  • carrier fluid as used herein is used interchangeably with “carrier oil”, and may refer to any liquid compound or a mixture thereof that is immiscible with water (or aqueous solution).
  • sample as used herein is not particularly limited as long as it contains a specimen to be detected.
  • a sample may be a biological sample, such as a biological fluid or a biological tissue.
  • the biological fluid include urine, blood, plasma, serum, saliva, semen, feces, sputum, cerebrospinal fluid, tears, mucus, amniotic fluid, and the like.
  • the biological tissue refers to a collection of cells, and typically, may be a collection of certain types of intracellular substances that form one of structural substances of human, animal, plant, bacterial, fungal, or viral structures.
  • the biological tissue include a connective tissue, an epithelial tissue, a muscle tissue, a neural tissue, and the like.
  • an organ, a tumor, a lymph node, artery, and an individual cell(s) may be included.
  • the term “reagent” as used herein refers to a compound or a set thereof, and/or a composition, which is bound to a sample to perform a specific test on the sample.
  • the reaction reagent may be an amplification reagent, specifically, a primer for amplifying a target nucleic acid, a probe and/or a dye for detecting an amplified product, a polymerase, a nucleotide (e.g., dNTP), a magnesium ion, a potassium chloride, a buffer, or any combination thereof.
  • the reagent reagent may include a distinctly barcoded particle (e.g., a bead).
  • Such a bead may include multiple nucleotides or oligonucleotides that are molecularly barcoded on a surface of the bead.
  • the multiple nucleotides or oligonucleotides may include a nucleotide sequence for capturing mRNA in the cells.
  • a sequence of the multiple nucleotides or oligonucleotides may include an oligo-dT sequence or a primer sequence.
  • the bead may be provided in a cell lysate or with a cell lysate.
  • amplification may refer to a reaction that occurs repeatedly to form multiple copies of at least one segment of a template molecule.
  • PCR refers to a reaction resulting in the formation of a large number of identical DNA strands from one original template by a cyclic process (alternative processes of heating and cooling).
  • the PCR consists of (i) a double helix DNA molecule that is a template having a base sequence to be amplified, (ii) a primer (a single-stranded DNA molecule capable of binding to a complementary DNA sequence in the template DNA), (iii) dNTP which is a mixture (i.e., a nucleotide subunit that is combined to form a new DNA molecule during PCR amplification) of dATP, dTTP, dGTP, and dCTP, and (iv) a Taq DNA polymerase (i.e., an enzyme for synthesizing a new DNA molecule by using dNTP).
  • a primer a single-stranded DNA molecule capable of binding to a complementary DNA sequence in the template DNA
  • dNTP which
  • complementary refers that a base pair between nucleotides or nucleic acids can be hybridized, and is typically associated with a pair of A and T (or U) or a pair of C and G.
  • channel refers to a passageway through which a fluid flows, and for example, may be formed in a tube (e.g., capillary), in a planar structure, on a planar structure (e.g., chip), or a combination thereof.
  • a channel in the present specification may be a channel extending along a planar flow path (e.g., a channel in a serpentine or spiral planar pattern) or a non-planar flow path (e.g., a three-dimensional spiral channel). That is, the inertial ordering may appear through a spiral channel of a microfluidic device to which the cells or the beads are provided.
  • the channel may have a spiral of at least two loops, at least three loops, or at least 5 loops, for example, between 2 loops and 20 loops, or between 5 loops and 15 loops.
  • the fluid flow within a microfluic channel may exhibit a poiseuille flow pattern, and when microparticles are present therein, a shear gradient lift force and a wall effect force that occurs at the channel walls are caused. Due to the interaction between the two forces applied on a particle, particles may be collected at a specific location, which is called inertia concentration.
  • the presence of particles may result in, in addition to the intensive movement of particles, a secondary flow that is formed by a change of the fluid flow, which can be seen as a force that pushes other particles or fluid around the particles.
  • a force is known to occur when the space, such as the microchannel, is limited or when the inertia of the fluid is applied.
  • inertial ordering Particles pushed out by this repulsive force are arranged at specific intervals, and such an arrangement is called inertial ordering.
  • the spiral channel can amplify the effect of the inertial ordering by using Dean flow. Therefore, as the inertial ordering is caused in the present disclosure, the ratio at which one cell and one bead are encapsulated in one droplet is improved, thereby improving a yield in which the droplet is produced.
  • a microfluidic device for forming droplet for single-cell analysis includes: a cell inlet 1 including a first channel 11 ; a bead inlet 2 including a second channel 21 ; an oil phase inlet 3 including a third channel 31 ; an intersection point 4 in which the first channel 11 , the second channel 21 , and the third channel 31 are combined; and an outlet 5 connected to the intersection point 4 and discharging droplet including a cell and a bead.
  • the microfluidic device of FIG. 3 may be configured to occur inertial ordering of cells or beads in the first channel 11 or the second channel 21 . That is, the first channel 11 and/or the second channel may be in a spiral form. As such, by occurring the inertial ordering of cells or beads in the first channel 11 and/or the second channel 21 , the microfluidic device according to an embodiment may not only improve the ratio at which one cell and one bead are encapsulated in one droplet, but also increase an output of droplet.
  • An aqueous state of the first channel 11 and/or the second channel 21 may have a flow rate of at least 1.0 ml/h or more, at least 1.6 ml/h or more, at least 2.0 ml/h or more, at least 2.4 ml/h or more, at least 2.8 ml/h or more, at least 3.0 ml/h or more, or at least 3.2 ml/h or more.
  • the flow rate of the aqueous phase may be in a range of 1.0 ml/h to 20 ml/h, 2.0 ml/h to 20 ml/h, 3.0 ml/h to 20 ml/h, 2.0 ml/h to 16 ml/h, 2.0 ml/h to 14 ml/h, 3.0 ml/h to 14 ml/h, or 3.2 ml/h to 14 ml/h.
  • an oil phase of the third channel 31 may have a flow rate of at least 2 ml/h or more, at least 4 ml/h or more, at least 6 ml/h or more, at least 8 ml/h or more, at least 10 ml/h or more, or at least 12 ml/h or more.
  • the flow rate of the oil phase may be in a range of 2.0 ml/h to 30 ml/h, 4.0 ml/h to 30 ml/h, 6.0 ml/h to 28 ml/h, 6.0 ml/h to 24 ml/h, 8.0 ml/h to 24 ml/h, 10 ml/h to 24 ml/h, or 12 ml/h to 24 ml/h.
  • a flow rate is an important factor in achieving effects of the present disclosure.
  • the flow rate of the oil phase is a significant factor in terms of the droplet-generation frequency.
  • the frequency increases with increasing flow rate of the oil phase, and in particular, may be preferably in a range of 4.0 ml/h to 18 ml/h, 4.0 ml/h to 10 ml/h, 4.0 ml/h to 8.0 ml/h, 6.0 ml/h to 8.0 ml/h, or 6.0 ml/h to 10 ml/h.
  • the flow rate of the aqueous phase in combination with the flow rate of the above-mentioned oil phase may be in a range of 3.0 ml/h to 14 ml/h, 4.0 ml/h to 14 ml/h, 5.0 ml/h to 14 ml/h, or 6.0 ml/h to 14 ml/h.
  • a combination of the flow rate of the oil phase in a range of 4.0 ml/h to 10 ml/h or 4.0 ml/h to 8.0 ml/h and the flow rate of the aqueous phase in a range of 5.0 ml/h to 14 ml/h or 6.0 ml/h to 14 ml/h, or a combination of the aforementioned flow rate ranges may be an optimal combination.
  • the droplet-generation frequency may be in a range of 1,000 Hz to 8,000 Hz, 1,000 Hz to 6,000 Hz, 2,000 Hz to 6,000 or 2,000 Hz to 4,000 Hz.
  • stable dripping and jetting modes may be achieved at the flow rate of the aforementioned combination.
  • a width of the first or second channel to induce inertial ordering may be in a range of 30 to 500 um, 50 to 400 um, 60 to 300 um, 60 to 250 um, or 80 to 160 um.
  • a height of the first or second channel to induce inertial ordering may be in a range of 30 to 500 um, 30 to 400 um, 50 to 300 um, 60 to 200 um, or 60 to 150 um.
  • a Reynolds number to induce inertial ordering may be at least 8.5, for example, in a range of 1 to 40, 8 to 40, 8.5 to 40, or 8.5 to 30.
  • a Dean number to induce inertial ordering may be at least 1.53, for example, in a range of 0.8 to 8, 1 to 8, 1.53 to 8, or 1.53 to 4.
  • a Particle Reynolds number to induce inertial ordering may be at least 0.62, for example, in a range of 0.3 to 3, 0.5 to 3, 0.62 to 3, or 0.62 to 1.
  • the cells, the beads, the oil phase, and the droplet may each be understood by referring to descriptions thereof provided herein.
  • each of the bead inlet 2 , and the oil phase inlet 3 may further include a filter 12 , 22 , 32 , respectively.
  • the filter may include square PDMS posts.
  • the outlet 5 may further include a mixing unit 51 for better mixing of cells and beads formed in the droplet.
  • one of or both the first channel 11 and the second channel 12 in the microfluidic device may be in a spiral form.
  • target cells may be introduced into the microfluidic device through the cell inlet 1
  • RNA of the introduced cells may be indexed through the bead inlet 2
  • beads attached with oligonucleotides for capturing mRNA may be introduced into the microfluidic device.
  • oil may be introduced into the microfluidic device through the oil inlet 3 .
  • the cells, the beads, and the oil that are introduced in this way are met at the intersection point 4 via the first channel 11 , the second channel 21 , and the third channel 31 , and then, droplets may be formed near the intersection point 4 .
  • the formed droplets may be discharged through the outlet 5 via the mixing unit 51 , and then, a process for subsequent sequencing analysis or the like may be performed thereon.
  • FIG. 2 Effects of an existing microfluidic device as shown in FIG. 2 and a microfluidic device according to an embodiment as shown in FIG. 3 are compared and analyzed.
  • K562 cells human
  • 293T cells human
  • NIH/3T3 cells human
  • the cells were cultured in a RMPI-1640 medium (supplemented with 10% FBS, 2 mM glutamine, and 1% PS), and the cells contained in PBS were used in this experiment.
  • RNA capture beads barcoded to distinguish individual cells barcoded beads (# MACOSKO-2011-10) with a PCR handle
  • 12-based cell barcode 8-based unique molecular identifier (UMI), and poly T site were purchased from manufactured from Chemgene Company.
  • TE/TW 10 mM Tris pH 8.0, 1 mM EDTA, 0.01% Tween
  • beads at a concentration of 500 beads/ul, 1,000 beads/ul, and 1,500 beads/ul were may be used.
  • a mixed solution containing 200 mM Tris, pH 7.5, 20 mM EDTA, 6% Ficoll PM400, 0.2% Sarcosyl, and 50 mM DTT was used, and the beads were contained in the cell lysate.
  • Droplet Generation Oil (Biorad #186-4006) was used.
  • a syringe pump had a rate of 14,000 ul/hr with oil and a rate of 4,100 ul/hr with the beads and the cells, and collected formed droplets in a falcon tube.
  • the cell suspension, bead suspension, and droplet generation oil were injected into a microfluidic device through three main inlets using syringe pumps (Lagato 210, KD Scientific, Holliston, Mass., USA). During injection, the cells and beads were continuously stirred in syringes by gentle magnetic mixing. In the microfluidic device, the cells and beads were co-encapsulated into 100 ⁇ m-diameter droplets.
  • serial images were captured at the spiral microchannel and channel junction with a high-speed camera (Phantom V7.3, Vision Research, Wayne, N.J., USA) equipped with an optical microscope (Ti-U, Nikon, Tokyo).
  • a high-speed camera Pantom V7.3, Vision Research, Wayne, N.J., USA
  • an optical microscope Telescope
  • inertial ordering, bead-entering frequency, and droplet generation modes were characterized while varying the flow rates.
  • the images were typically acquired at 5,000-10,000 frames per second.
  • the produced droplets were collected in tubes, and then, loaded onto a dish. The occupancy of cells and beads in the droplets was evaluated by observing aliquots of droplets under an optical microscope (Ti-U, Nikon) and a fluorescence microscope (X81, Olympus, Tokyo, Japan).
  • a microfluidic device according to an embodiment of the present disclosure is the microfluidic device of FIG. 3 .
  • the existing microfluidic device constituted a channel through which beads move as shown in FIG. 2
  • the microfluidic device according to the present disclosure constituted a channel through which beads move as shown in FIG. 3 .
  • the alignment of beads in each channel was observed, and results thereof are shown in FIGS. 5A and 5B .
  • FIG. 5A is a photograph showing the alignment of particles using the existing microfluidic device.
  • FIG. 5B shows the alignment of particles using the microfluidic device according to an embodiment of the present disclosure.
  • the microfluidic device according to an embodiment of the present disclosure constitutes a channel in a spiral form, and accordingly, it was confirmed that the behavior of particles in the microfluidic device was made smoothly compared to the existing microfluidic device.
  • the cell throughput per hour and the ratio of cells encapsulated in droplets in the aforementioned existing microfluidic device and the microfluidic device according to an embodiment of the present disclosure were analyzed according to the concentration of beads.
  • the existing system used beads at the concentration of 500 beads/ul, 1,000 beads/ul, and 1,500 beads/ul
  • the system according to an embodiment of the present disclosure used beads at the concentration of 1,500 beads/ul.
  • the cell yield indicates a ratio at which one cell and one bead are encapsulated in one droplet
  • the cell throughput indicates the number of cells encapsulated per unit time. The results of the analysis are shown in FIGS. 6 and 7 .
  • FIG. 6 is a graph showing the cell throughput per time and the cell yield per time according to the bead concentration in the microfluidic device according to an embodiment of the present disclosure as compared to the existing system, wherein p indicates the existing system, and o indicates the system according to an embodiment of the present disclosure.
  • the existing system included more double or multi-cells in which two or more cells were encapsulated in one droplet, and accordingly, it was confirmed that the existing system has no choice but to maintain a low concentration.
  • the system according to an embodiment of the present disclosure used the inertial ordering, particles and cells at a high concentration could be introduced, and accordingly, it was confirmed that the cell yield was also able to be significantly increased.
  • FIG. 7 is a graph showing a ratio of the number of cells encapsulated in droplets according to the bead concentration in the microfluidic device according to an embodiment of the present disclosure, as compared to the existing system, wherein p indicates the existing system, o indicates the system according to an embodiment of the present disclosure, 1 indicates a case where the number of cells to be encapsulated in droplet is one, 2 indicates a case where the number of cells to be encapsulated in droplet is two, and m indicates a case where the number of cells to be encapsulated in droplet is three or more.
  • a high frequency of droplet generation and encapsulation of beads were prerequisites.
  • the encapsulation was achieved by synchronization of the bead inlet with the droplet generation.
  • two aqueous phases, Qw were varied. No cells and beads were included in the aqueous phases, and the flow rates of the aqueous phases were set to Qw/2. Meanwhile, a rate of discharge of the carrier oil, Qo, was set to 12 ml/h.
  • the inertial and secondary flow act together on the beads for them to laterally migrate into a single focusing position.
  • the single focusing position lies near the inner wall because the drag force originated from the Dean flow guides the beads toward the inner wall.
  • the inertial effect and parabolic flow field longitudinally arrange the focused beads with even spacing, as shown in FIG. 8A . Higher inertia is imparted by increasing the flow rate, thereby enhancing focusing and ordering. In this regard, the influence of the flow rate on inertial focusing with a lateral position was investigated.
  • the flow rate varied in the range of 1.6 mL to 3.2 mL and the lateral positions of 300 beads from the inner wall at the end of the spiral channel were measured for each flow rate.
  • the bead concentration was set to 500 beads per ⁇ l for all conditions, and the results are shown in FIG. 8B .
  • FIG. 8A is a diagram showing the lateral position in the spiral channel according to an embodiment.
  • FIG. 8B is a graph showing the bead distribution along the length of the lateral position in the spiral channel according to an embodiment.
  • the fraction distribution had a kurtosis of 2.85 at a flow rate of 1.6 mL/h.
  • the flow rate increased to 2.4 mL/h, beads were focused and the kurtosis was increased to 3.39.
  • a lateral position showed an unimodal distribution with a kurtosis of 5.63. Based on these results, it was confirmed that the flow rate for the droplet generation was at least 1.6 mL/h or higher.
  • the frequency of droplet generation was adjusted while maintaining the flow rates at a Qw/2 of 3.2 mL and Qo of 12 mL.
  • the beads form trains with even spacing at low concentration under the condition of finite inertia, the separation between two following beads is very large, resulting in small bead-free droplets.
  • the average number of beads in each train increases and the separation decreases.
  • the inter-bead distance in each train decreases, thereby increasing the bead insertion frequency. Therefore, when the bead-entering frequency exceeds the drop-generation frequency at a very high concentration of beads, droplets containing multiple beads are produced, causing intermittent errors in cell indexing.
  • the cells encapsulated with multiple beads result in intermittent errors as mRNAs of a single cell are distributed to several beads. Therefore, it was intended to maximize the fraction of droplets containing a single bead (1B) and minimize the fraction of droplets containing multiple beads (mB).
  • the bead concentration varied in a range of 100 beads per ⁇ L to 1,250 beads per ⁇ L, and 1B and mB were measured from droplets collected from the outlet. The results are shown in FIG. 9B .
  • An example of the collected droplets is shown in FIG. 9A .
  • FIG. 9A is an optical microscope image showing the droplets collected by using the microfluidic device according to an embodiment, wherein a scale bar herein is 200 um.
  • FIG. 9B is a graph showing the fractions (%) of droplets containing a single bead and droplets containing multiple beads collected according to the bead concentration by using the microfluidic device according to an embodiment.
  • the cell yield defined as the fraction of cells encapsulated one-to-one with a bead for all cells, was estimated from images of collected droplets.
  • the throughput defined as the number of droplets containing one cell and one bead produced in a given period, was calculated as a product of the fraction of droplets containing one cell and one bead for all droplets and droplet-generation frequency.
  • the results of the encapsulation of the one bead and the one cell in the one droplet in the microfluidic device according to an embodiment and the existing microfluidic device are shown in FIGS. 10B and 10 C, respectively.
  • FIG. 10A is a graph showing the throughput and the cell yield according to the bead concentration in the microfluidic device according to an embodiment.
  • FIG. 10B is a graph showing the fraction of droplets containing a single cell and a single bead according to the bead concentration in the microfluidic device according to an embodiment.
  • FIG. 10C is a graph showing the fraction of droplets containing a single cell and a single bead according to the bead concentration in the microfluidic device according to an embodiment.
  • both the throughput and the cell yield increased along with the bead concentration.
  • the throughput and cell yield is 2,700 cells per min and 20%, respectively, which are much higher than the values of 300 cells per min and 3% with 100 beads per ⁇ L. This implies that 20%, which is higher than the existing device, of input cells are able to be co-encapsulated with a bead.
  • These large values are ascribed to the high fraction of one-bead-in-droplet achieved by the encapsulation according to an embodiment. Based on the increased probability that a cell meets a bead, the probability of cell encapsulation with a bead can consequentially be increased.
  • the fractions of droplets containing one cell and one bead (1C+1B), multiple cells and one bead (mC+1B), one cell and multiple beads (1C+mB), and multiple cells and multiple beads (mC+mB) are analyzed, and as a result, 1C+1B was as high as 95% and the sum of 1C+mB and mC+mB was as low as 2% over the entire range of bead concentrations in the microfluidic device according to an embodiment.
  • the droplets containing multiple beads are found to appear at a very low ratio even at high bead concentration, referring that the microfluidic device according to an embodiment is beneficial for single-cell analysis, compared to a platform of the existing microfluidic device.
  • errors in cell indexing can be reduced by maintaining a low fraction of multiple-beads-in-droplets.
  • 1C+mB substantially increased up to 20% as shown in FIG. 10C .
  • the results imply that the encapsulation in the microfluidic device according to an embodiment maximized the fraction of one bead-in-droplets while minimizing the fractions of empty droplets and multiple-beads-in-droplets. Therefore, a large fraction of encapsulated single cells was captured with a single bead, Increasing the cell yield while decreasing errors in cell indexing, making the microfluidic device according to an embodiment suitable for high throughput single-cell analysis.
  • a cell suspension of HEK293T and NIH3T3 cells was injected at 250 cells per ⁇ L, and a barcoded bead suspension was injected at 1,000 beads per ⁇ L into the device. After encapsulation, mixing, cell lysis, and mRNA capture, droplets were collected for 2.5 minutes from the outlet. Then, beads collected from the droplets were subjected to reverse transcription, amplification, library preparation, and sequencing.
  • the nucleotide ratio of the cell index and molecular index of read 1 was calculated. From the sequencing data set, 2,165 cells (over 686 UMIs per cell) in the existing microfluidic device and 1,719 cells (over 702 UMIs per cell) in the microfluidic device according to an embodiment were collected based on the cumulative fraction of UMIs curves. Among the selected cells, 229 cells in the existing microfluidic device and 282 cells in the microfluidic device according to an embodiment were discarded as low-quality cells. Afterwards, density plot analysis was performed on the UMIs per cell, and the results are shown in FIG. 11 .
  • FIG. 11A is a graph showing the density plot of UMIs per cell of combined human and mouse cells according to the existing microfluidic device (Unordered) and the microfluidic device according to an embodiment (Ordered).
  • FIG. 11B is a graph showing density plot of UMIs per cell of only human cells according to the existing microfluidic device (Unordered) and the microfluidic device according to an embodiment (Ordered).
  • FIG. 11B is a graph showing the density plot of UMIs per cell of only human cells in the existing microfluidic device (Unordered) and the microfluidic device according to an embodiment (Ordered).
  • the number of UMIs at the top peak in the microfluidic device according to an embodiment was 2,179, whereas that of the existing microfluidic device was 866, which is less than half, and a similar pattern was observed for human cells only and mouse cells only.
  • the transcript number was halved because mRNA fragments were divided into two for capture by two barcoded beads.
  • the number of cells was duplicated as two barcoded beads were sequenced individually. The results of FIG. 11 indicate that bead doublets generated by the encapsulation in the existing microfluidic device significantly reduce the quality of single-cell sequencing data by underestimating the transcript number and overestimating the cell number.
  • results of FIG. 11 also indicate that inaccurate transcript and cell numbers caused by bead doublet-mediated barcoding error can mislead the single-cell mRNA profile. Meanwhile, it was confirmed that the encapsulation in the microfluidic device according to an embodiment enable high-throughput barcoding and while minimizing barcoding errors.
  • the existing system increased the probability of entering two or more clusters with the increased concentrations of the cell and the bead, and when the concentrations of the cell and the bead decreased, the cell and the bead were less likely to meet to form droplets, resulting in lower efficiency (yield). Meanwhile, it was also confirmed that the system according to an embodiment formed droplets by the inertial ordering of the cells or the beads, thereby simultaneously improving two conflicting parameters described above and minimizing the barcoding errors.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Clinical Laboratory Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Fluid Mechanics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
US16/686,613 2017-05-17 2019-11-18 Method and Device for Encapsulating Cell in Liquid Droplet for Single-Cell Analysis Abandoned US20200086321A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/962,752 US12226773B2 (en) 2017-05-17 2022-10-10 Method and device for encapsulating cell in liquid droplet for single-cell analysis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0061053 2017-05-17
KR20170061053 2017-05-17
PCT/KR2018/005646 WO2018212603A1 (fr) 2017-05-17 2018-05-17 Procédé et dispositif pour encapsuler une cellule dans une gouttelette liquide pour l'analyse d'une seule cellule

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/005646 Continuation-In-Part WO2018212603A1 (fr) 2017-05-17 2018-05-17 Procédé et dispositif pour encapsuler une cellule dans une gouttelette liquide pour l'analyse d'une seule cellule

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/962,752 Division US12226773B2 (en) 2017-05-17 2022-10-10 Method and device for encapsulating cell in liquid droplet for single-cell analysis

Publications (1)

Publication Number Publication Date
US20200086321A1 true US20200086321A1 (en) 2020-03-19

Family

ID=64274351

Family Applications (2)

Application Number Title Priority Date Filing Date
US16/686,613 Abandoned US20200086321A1 (en) 2017-05-17 2019-11-18 Method and Device for Encapsulating Cell in Liquid Droplet for Single-Cell Analysis
US17/962,752 Active 2038-11-26 US12226773B2 (en) 2017-05-17 2022-10-10 Method and device for encapsulating cell in liquid droplet for single-cell analysis

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/962,752 Active 2038-11-26 US12226773B2 (en) 2017-05-17 2022-10-10 Method and device for encapsulating cell in liquid droplet for single-cell analysis

Country Status (3)

Country Link
US (2) US20200086321A1 (fr)
KR (1) KR102136328B1 (fr)
WO (1) WO2018212603A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755332A (zh) * 2021-10-08 2021-12-07 临沂大学 具有高时间分辨率的单液滴更替捕获微芯片系统及其应用
CN114164104A (zh) * 2021-12-03 2022-03-11 大连理工大学 一种基于微流控芯片的单细胞非牛顿液滴封装装置及方法
CN114540182A (zh) * 2022-04-14 2022-05-27 严一喆 一种基于单细胞水平检测循环肿瘤细胞分泌物的微流控系统及其使用方法
EP4371665A1 (fr) * 2022-11-17 2024-05-22 Imec VZW Procédé et appareil pour surveiller un matériau de surveillance d'un processus
WO2024102720A3 (fr) * 2022-11-07 2024-06-20 Shennon Biotechnologies Inc. Dispositifs microfluidiques pour le criblage à haut débit d'interactions cellule-cellule
EP4434627A1 (fr) * 2023-03-24 2024-09-25 Ecole Polytechnique Federale De Lausanne (Epfl) Dispositif et procede de production d'un microcompartiment combinatoire a l'interieur d'une phase porteuse
CN119639558A (zh) * 2024-12-13 2025-03-18 杭州海兰时生物科技有限责任公司 一种用于单细胞测序的液滴融合系统

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110437357B (zh) * 2019-08-12 2020-05-05 四川大学 功能微螺旋及其制备方法
WO2021222512A1 (fr) * 2020-04-30 2021-11-04 Dimensiongen Dispositifs et procédés pour la manipulation macromoléculaire
KR102702774B1 (ko) * 2020-12-09 2024-09-05 고려대학교 산학협력단 위치기반 단일 세포 유전자 발현 분석 방법 및 장치
CN114717100B (zh) * 2021-07-16 2024-03-19 墨卓生物科技(浙江)有限公司 一种用于单细胞测序的微流控芯片及应用
CN113617403A (zh) * 2021-08-05 2021-11-09 上海交通大学 一种新型单细胞western blot的微流控芯片

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110223314A1 (en) * 2010-03-10 2011-09-15 Xiaoxiao Zhang Efficient microencapsulation
GB201300957D0 (en) * 2013-01-18 2013-03-06 Base4 Innovation Ltd Sequencing method
WO2015200717A2 (fr) * 2014-06-27 2015-12-30 The Regents Of The University Of California Tri activé par pcr (pas)
CN107873054B (zh) * 2014-09-09 2022-07-12 博德研究所 用于复合单细胞核酸分析的基于微滴的方法和设备
GB201516447D0 (en) * 2015-09-16 2015-10-28 Sphere Fluidics Ltd Microfluidic structure
WO2017048975A1 (fr) * 2015-09-17 2017-03-23 The Regents Of The University Of California Dispositifs de piégeage de gouttelettes pour des dosages biologiques et des diagnostics
JP7341661B2 (ja) * 2015-09-25 2023-09-11 アブビトロ， エルエルシー ネイティブに対合するｔ細胞受容体配列のｔ細胞受容体標的識別のための高スループットプロセス
CA3001679A1 (fr) * 2015-10-13 2017-04-20 President And Fellows Of Harvard College Systemes et procedes de fabrication et d'utilisation de microspheres de gel
KR20180079443A (ko) * 2015-11-10 2018-07-10 일루미나, 인코포레이티드 관성 소적 생성 및 입자 캡슐화

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755332A (zh) * 2021-10-08 2021-12-07 临沂大学 具有高时间分辨率的单液滴更替捕获微芯片系统及其应用
CN114164104A (zh) * 2021-12-03 2022-03-11 大连理工大学 一种基于微流控芯片的单细胞非牛顿液滴封装装置及方法
CN114540182A (zh) * 2022-04-14 2022-05-27 严一喆 一种基于单细胞水平检测循环肿瘤细胞分泌物的微流控系统及其使用方法
WO2024102720A3 (fr) * 2022-11-07 2024-06-20 Shennon Biotechnologies Inc. Dispositifs microfluidiques pour le criblage à haut débit d'interactions cellule-cellule
US12391914B2 (en) 2022-11-07 2025-08-19 Shennon Biotechnologies Inc. Microfluidic devices for high throughput screening of cell-cell interactions
EP4371665A1 (fr) * 2022-11-17 2024-05-22 Imec VZW Procédé et appareil pour surveiller un matériau de surveillance d'un processus
EP4434627A1 (fr) * 2023-03-24 2024-09-25 Ecole Polytechnique Federale De Lausanne (Epfl) Dispositif et procede de production d'un microcompartiment combinatoire a l'interieur d'une phase porteuse
WO2024200381A1 (fr) * 2023-03-24 2024-10-03 Ecole polytechnique fédérale de Lausanne (EPFL) Dispositif et procédé de fabrication d'un micro-compartiment combinatoire à l'intérieur d'une phase porteuse
CN119639558A (zh) * 2024-12-13 2025-03-18 杭州海兰时生物科技有限责任公司 一种用于单细胞测序的液滴融合系统

Also Published As

Publication number Publication date
KR102136328B1 (ko) 2020-07-22
US20230030813A1 (en) 2023-02-02
KR20180126407A (ko) 2018-11-27
US12226773B2 (en) 2025-02-18
WO2018212603A1 (fr) 2018-11-22

Similar Documents

Publication Publication Date Title
US12226773B2 (en) Method and device for encapsulating cell in liquid droplet for single-cell analysis
US20230109667A2 (en) PCR-Activated Sorting (PAS)
US9840732B2 (en) Single-particle analysis of particle populations
US20220154248A1 (en) Combined multiple-displacement amplification and pcr in an emulsion microdroplet
US9493816B2 (en) Composite liquid cells
JP2022088360A (ja) 別個の実体におけるバーコード付加による核酸のシーケンシング
CN103890245B (zh) 核酸编码反应
US10626446B2 (en) Analyte enrichment methods and compositions
Ding et al. From single-molecule detection to next-generation sequencing: microfluidic droplets for high-throughput nucleic acid analysis
KR20180097536A (ko) 단일 세포와 연관된 핵산의 분석을 위한 핵산 바코드의 조합 세트
CN114045328B (zh) 单细胞分析
EP3525933B1 (fr) Systèmes et procédés pour encapsuler et conserver une matière organique en vue d'une analyse
JP2021509024A (ja) 多数の液滴の捕捉
CN108315389B (zh) 一种微体积细胞核酸扩增方法
US20250320489A1 (en) Double-layer microsphere with oligonucleotide sequence for single-cell sequencing
US20170275679A1 (en) Use of gel beads to control droplet dispersion
WO2025235657A1 (fr) Procédés d'encapsulation cellulaire pour séquençage unicellulaire amélioré
WO2023138655A1 (fr) Distribution de gouttelettes réglables
HK40117534A (zh) 单细胞分析

Legal Events

Date Code Title Description
AS Assignment

Owner name: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PARK, WOONG-YANG;MOON, HUI-SUNG;KIM, SHIN-HYUN;AND OTHERS;REEL/FRAME:051401/0947

Effective date: 20191126

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION